Lenshil Tablets (Lenvatinib): Strengths, Uses, Benefits and Side Effects

What Is Lenshil (Lenvatinib)?

Lenshil is a brand of lenvatinib, an oral targeted anticancer medicine used under specialist supervision to treat certain types of cancer. It belongs to a group of medicines called tyrosine kinase inhibitors (TKIs), which block specific proteins involved in tumour growth and the formation of blood vessels that supply tumours.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information to support healthcare professionals, distributors and other authorised pharmaceutical-sector partners. Patients in Singapore should consult their oncologist or pharmacist to confirm product suitability, availability and local regulatory status before considering this medicine.

Lenshil Strengths and Product Information

Lenshil is available in different strengths in certain markets. Reported strengths include 4 mg & 10 mg. Availability, dosage forms and approved presentations may vary by country and supplier. Confirm the exact product, strength and formulation against the current packaging and official product information.

Lenvatinib dosing depends on the cancer being treated, the patient's condition, other medicines and tolerability. Only an authorised healthcare professional should determine the appropriate dose. Do not change the dose, stop treatment or combine medicines without medical advice.

Uses and Potential Benefits of Lenvatinib

Depending on the approved product information and treatment regimen, lenvatinib may be prescribed for certain patients with:

Differentiated thyroid cancer that has progressed despite radioactive iodine treatment.

Unresectable hepatocellular carcinoma, a type of liver cancer.

Advanced renal cell carcinoma (kidney cancer), in combination with another medicine.

Advanced endometrial cancer in selected treatment settings, often in combination with pembrolizumab.

The potential benefit of lenvatinib is its targeted action against pathways that help cancer cells grow and develop a blood supply. It may help control disease in eligible patients. The treatment response varies, and it is not suitable for every cancer or patient.

Lenshil (Lenvatinib) Side Effects

Lenvatinib can cause side effects that require regular medical monitoring. Common or recognised adverse effects include:

High blood pressure.

Diarrhoea, nausea and vomiting.

Reduced appetite and weight loss.

Tiredness and weakness.

Mouth sores.

Protein in the urine.

Headache and changes in voice.

Hand-foot skin reactions.

Serious complications can include severe hypertension, bleeding, blood clots, liver problems, kidney problems, heart complications and gastrointestinal perforation. Seek urgent medical care for chest pain, severe breathlessness, major bleeding, sudden neurological symptoms or severe abdominal pain.

Tell your doctor about existing medical conditions, pregnancy or plans to become pregnant, breastfeeding, and all prescription medicines, supplements and herbal products. Lenvatinib can harm an unborn baby, so pregnancy-prevention advice is important.

Frequently Asked Questions (FAQs)

1. What is Lenshil used for?

Lenshil contains lenvatinib, a targeted cancer medicine prescribed for specific cancers according to the approved indication and treatment regimen.

2. Is Lenshil available in Singapore?

Availability and registration depend on the exact product and strength. Check the Singapore Health Sciences Authority (HSA) product information or consult a licensed local healthcare professional.

3. What strengths of Lenshil are available?

Reported presentations include 4 mg & 10 mg in some markets. Confirm the strength and formulation on the official product label.

4. Can I take Lenshil without a prescription?

No. Lenvatinib requires specialist medical supervision, prescription oversight and appropriate monitoring.

5. How can I manage side effects?

Contact your oncology team about any new or worsening symptoms. Do not adjust the dose independently, and seek urgent care for serious symptoms.

Product Information and Enquiries

For product documentation or authorised pharmaceutical-sector enquiries, contact Cordium Pharmaceuticals Pvt Ltd through its verified business channels. Singapore buyers should independently verify local registration, import authorisation, supply eligibility and applicable requirements before placing an order.

Medical disclaimer: This page is for general educational purposes and is not a substitute for professional medical advice, diagnosis or treatment. Product indications, strengths and availability must be verified against the current approved product information applicable in Singapore.